Buscar resultados de ensayos clínicos
Angioimmunoblastic Lymphadenopathy With Dysproteinemia - 244 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study Condición:
|
Recruiting |
Nombre del estudio: Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma Condición:
|
Completed |
Nombre del estudio: RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas Condición:
Intervenciones: Drug: RAD001 (Everolimus) Phase I Level 1: RAD001 2.5 mg PO daily D1-14 + CHOP Level 2: RAD001 5 mg PO d |
Active, not recruiting |
Nombre del estudio: Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma Condición:
Intervenciones: Drug: carfilzomib Given IV Other Names: |
Recruiting |
Nombre del estudio: Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma Condición:
|
Recruiting |
Nombre del estudio: VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, or T-cell Lymphoma Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Condición:
|
Recruiting |
Nombre del estudio: CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Condición:
|
Recruiting |
Nombre del estudio: CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Condición:
|
Terminated |
Nombre del estudio: Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Condición:
|